Assessment of Prognostic Value of High-Sensitivity Cardiac Troponin T for Early Prediction of Chemoradiation Therapy-Induced Cardiotoxicity in Patients with Non-Small Cell Lung Cancer: A Secondary Analysis of a Prospective Randomized Trial

Journal Article · Mon Nov 15 04:00:00 EST 2021 · International Journal of Radiation Oncology, Biology and Physics

DOI:https://doi.org/10.1016/J.IJROBP.2021.07.035· OSTI ID:23200936

Xu, Ting; Meng, Qing H.; Gilchrist, Susan C.; Lin, Steven H.; Lin, Ruitao ^[1]; others, and

---

1. Departments of Radiation Oncology, Laboratory Medicine, Clinical Cancer Prevention and Cardiology, Biostatistics, University of Texas MD Anderson Cancer Center, Houston (United States)

Cardiotoxicities induced by cancer therapy can negatively affect quality of life and survival. We investigated whether high-sensitivity cardiac troponin T (hs-cTnT) levels could serve as biomarker for early detection of cardiac adverse events (CAEs) after chemoradiation therapy (CRT) for non-small cell lung cancer (NSCLC).

• OSTI ID: 23200936
• Journal Information: International Journal of Radiation Oncology, Biology and Physics, Journal Name: International Journal of Radiation Oncology, Biology and Physics Journal Issue: 4 Vol. 111; ISSN IOBPD3; ISSN 0360-3016
• Country of Publication: United States
• Language: English

Related Subjects

62 RADIOLOGY AND NUCLEAR MEDICINE
BIOLOGICAL MARKERS
LUNGS
NEOPLASMS
PATIENTS
QUALITY OF LIFE
RADIOTHERAPY
SENSITIVITY